Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition

Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition

<p>Abstract</p> <p>Background</p> <p>Gastric cancer is the second leading cause of cancer mortality in the world. The receptor tyrosine kinase MET is constitutively activated in many gastric cancers and its expression is strictly required for survival of some gastric ca...

Full description

Bibliographic Details
Main Authors:	Bertotti Andrea, Migliore Cristina, Sierra J Rafael, Cepero Virna, Ghiso Elena, Corso Simona, Trusolino Livio, Comoglio Paolo M, Giordano Silvia
Format:	Article
Language:	English
Published:	BMC 2010-05-01
Series:	Molecular Cancer
Online Access:	http://www.molecular-cancer.com/content/9/1/121

Similar Items

Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
by: Cepero Virna, et al.
Published: (2010-04-01)

SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells
by: Robert Jenke, et al.
Published: (2021-12-01)

miR‐205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling
by: Cristina Migliore, et al.
Published: (2018-09-01)

Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors
by: Yıldız Y, et al.
Published: (2016-09-01)

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin
by: Giulia M. Stella, et al.
Published: (2017-10-01)

Evaluation of HER2, MDM2, MYC, MET and TP53 gene copy number alterations in gastric cancer patients
by: Fatemeh Nevisi, et al.
Published: (2020-01-01)

Molecularly Targeted Therapies for Gastric Cancer. State of the Art
by: Rossella Reddavid, et al.
Published: (2021-08-01)

Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
by: Chiara Modica, et al.
Published: (2020-03-01)

Saint Praxedes and the Church which met in her house in Rome
by: Ivoni Richter Reimer
Published: (2015-10-01)

MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
by: Zhiqiang Zheng, et al.
Published: (2015-01-01)

Inhibition of HER Receptors Reveals Distinct Mechanisms of Compensatory Upregulation of Other HER Family Members: Basis for Acquired Resistance and for Combination Therapy
by: Daniela Gutsch, et al.
Published: (2021-01-01)

The Significance of MET Expression and Strategies of Targeting MET Treatment in Advanced Gastric Cancer
by: Haiyan Liao, et al.
Published: (2021-09-01)

A receptor-antibody hybrid hampering MET-driven metastatic spread
by: Chiara Modica, et al.
Published: (2021-01-01)

MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk
by: Chiara Modica, et al.
Published: (2018-12-01)

An Association member stands and smiles for her photograph.
Published: ()

An Association member stands and smiles for her photograph.
Published: ()

Osthole Synergizes With HER2 Inhibitor, Trastuzumab in HER2-Overexpressed N87 Gastric Cancer by Inducing Apoptosis and Inhibition of AKT-MAPK Pathway
by: Yun Yang, et al.
Published: (2018-11-01)

YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
by: Elena Ghiso, et al.
Published: (2017-12-01)

MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression
by: Yang Peng, et al.
Published: (2014-06-01)

Foretinib Inhibits Cancer Stemness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling
by: Sohn SH, et al.
Published: (2020-02-01)

HGF and MET: From Brain Development to Neurological Disorders
by: Claudia Desole, et al.
Published: (2021-06-01)

Mediterranean gastric remittent fever as it is met with in Great Britain
by: Tullis, George Augustus
Published: (1887)

Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis.
by: Peng Ye, et al.
Published: (2015-01-01)

Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification
by: Doo-Yi Oh, et al.
Published: (2017-08-01)

Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models
by: Valentina Belli, et al.
Published: (2019-06-01)

An Association member smiles at the camera as her photograph is taken.
Published: ()

Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?
by: Angela Dalia Ricci, et al.
Published: (2021-04-01)

Role of HER2neu expression in gastric cancer
by: J S Sukanya, et al.
Published: (2021-01-01)

Recombinant immunotoxin anti-c-Met/PE38KDEL inhibits proliferation and promotes apoptosis of gastric cancer cells
by: Hua Zhang, et al.
Published: (2011-07-01)

Practical consensus recommendations on Her2 +ve breast cancer with solitary brain mets
by: Nitesh Rohatgi, et al.
Published: (2018-01-01)

MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
by: El Darsa H, et al.
Published: (2020-10-01)

Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
by: Yu Ishimine, et al.
Published: (2015-01-01)

Re-Membering Ancient Women: Hypatia of Alexandria and her Communities
by: Minardi, Cara
Published: (2011)

Re-Membering Ancient Women: Hypatia of Alexandria and her Communities
by: Minardi, Cara
Published: (2011)

female staff member seated at her desk smiles for the camera.
Published: ()

The potential of panHER inhibition in cancer
by: Xiaochun eWang, et al.
Published: (2015-01-01)

Her2+ and b-HCG Producing Undifferentiated Gastric Adenocarcinoma
by: Sahar Eivaz-Mohammadi, et al.
Published: (2014-01-01)

Her2-Positive and Microsatellite Instability Status in Gastric Cancer—Clinicopathological Implications
by: Ana Bermúdez, et al.
Published: (2021-05-01)

The baker's wife and her confidante in Apuleius, Met. IX 14 ff.: some liturgiological considerations
by: David Tripp
Published: (1988-12-01)

Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas
by: Tang D, et al.
Published: (2014-12-01)